Profile
ABOS VRTX ALNY REGN ARGX SGEN
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $103.58M $100.41B $59.77B $58.57B $48.77B $43.15B
Employees 0.06K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Daniel J. O'Connell Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABOS VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
ABOS VRTX ALNY REGN ARGX SGEN
Last Close $1.88 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $3.27 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $0.9 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -42.51 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 108.89 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
ABOS VRTX ALNY REGN ARGX SGEN
1 Month Return 30.56 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 50.4 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 77.36 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 10.59 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 9.3 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return -17.9 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1338.23 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
ABOS VRTX ALNY REGN ARGX SGEN
Asset Growth -22.94 % -0.87 %
Gross Profit Growth 99.58 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year -100 % 163.93 %
Revenue 10 Year -100 % 1632.15 %
EBIT Growth -89.73 % -93.69 %
Net Income Growth -95.39 % -114.8 %
Net Income 3 Yeari Growth Per Share 35.14 % -122.89 %
Net Income 5 Yeari Growth Per Share -517.86 % -145.38 %
Net Income 10 Yeari Growth Per Share -517.86 % 33.84 %
Operating Income Growth -86.49 % -106.08 %
Operating Cash Flow Growth (CFG) -100.2 % -113.93 %
Operating 3 Year CFG -206.07 % -118.65 %
Operating 5 Year CFG -503.71 % -131.3 %
Operating 10 Year CFG -503.71 % 12.43 %
EPS Growth -58.33 % -114.8 %
EPS Diluted Growth -58.33 % -114.97 %
Book Value Per Share -44.97 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -48.52 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 860.1 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 860.1 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -4.33 % 116.42 %
Free Cash Flow Growth -100.14 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ABOS VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -0.56 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -79.5 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -81.39 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -97.92 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 94.92 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -80888.76 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -394.1 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.09 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.1 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -1.94 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -1.95 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 236.69 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -66159.55 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -394.1 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.88 28.69 -1147.52 15.23 124.07 -81.26
Price To Operating Cash Flows Ratio TTM -0.88 26.14 -3805.41 12.46 141.63 -93.1
Price Cash Flow Ratio TTM -0.88 26.14 -3805.41 12.46 141.63 -93.1
Income Statement (TTM)
ABOS VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.1B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.71 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABOS VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.03B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.06B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.18B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.2B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.03B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.24B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABOS VRTX ALNY REGN ARGX SGEN
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.09B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.23
AARD Aardvark Therapeutics, Inc. Common Stock 17.13
ABCL AbCellera Biologics Inc. 6.17
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.54
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.0255
ABSI Absci Corporation 4.18
ABUS Arbutus Biopharma Corporation 4.18
ABVC ABVC BioPharma, Inc. 3.24
ABVX Abivax SA American Depositary Shares 86.51
ACAD ACADIA Pharmaceuticals Inc. 21.31
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9287
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.45
ACIU AC Immune SA 3.52
ACLX Arcellx, Inc. 88.29
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 246.72
VTI Vanguard Total Stock Market Index Fund 0.00008 331.81
IBB iShares Biotechnology ETF 0.01258 151.99
IWN iShares Russell 2000 Value ETF 0.00035 179.13
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 65.5747
VXF Vanguard Extended Market Index Fund 0.00053 212.75
HDG ProShares Hedge Replication ETF 0.000269689 51.43
UWM ProShares Ultra Russell2000 0.00157102 48.09
VTHR Vanguard Russell 3000 Index Fund 0 297.376
IWC iShares Micro-Cap ETF 0.01462 154.2
URTY ProShares UltraPro Russell2000 0.00125687 55.95
VTWV Vanguard Russell 2000 Value Index Fund 0.00373 157.852
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0.00168 99.68
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 47.085
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 112.84
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00017 112.81
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.85
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.84
VBINX Vanguard Balanced Index Fund Investor Shares 0.00006 52.85
BMED BlackRock Future Health ETF 0.03 27.885
DFAU Dimensional US Core Equity Market ETF 0.00048189 46.2
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 25.541
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 58.38
DFAS Dimensional U.S. Small Cap ETF 0.0001142 68.86
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 38.85
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 6.442
VTSAX Vanguard Total Stock Market Index Fund 0.00008 161.49
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 7.48
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00053 161.41
VITSX Vanguard Total Stock Market Index Fund 0.00008 161.52
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 7.4475
IBRN iShares Neuroscience and Healthcare ETF 0.17376 27.7157
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 16.36
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00053 161.42
AVSC Avantis U.S. Small Cap Equity ETF 0 57.69
VTS.AX Vanguard US Total Market Shares Index ETF 0.00008 502.2
DCOR Dimensional ETF Trust 0.00005219 72.4
VEMPX Vanguard Extended Market Index InstlPlus 0.00053 398.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00008 302.98
RSSL Global X Funds 0 96.78
DXUV Dimensional ETF Trust 0.0000186 58.76
Unlock